REVEAL III: Risk Evaluation and Education for Alzheimer's Disease

Completed · Not applicable

Conditions studied: Alzheimer Disease

In brief

The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.

Key facts

Study ID

NCT00462917

Run by

Brigham and Women's Hospital

People needed

290

Starts

2007-03-01

Expected to finish

2009-10-01

Last updated by the study team

2018-10-23

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 18 years to 85 years old

You may not qualify if…

• Unable to visit a study site
• Current untreated depression or anxiety
• Family history of AD diagnosed under age 60
• More than one first-degree relative diagnosed with AD (e.g. Mother and brother)

Where it is running

• Howard University — Washington D.C., District of Columbia, United States
• Boston University School of Medicine — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Case Western Reserve University — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.